Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,132.50    1.50 (0.13%)
Bid:
1,137.00
Ask:
1,138.00
Spread: 1.00 (0.088%)
Market Cap: £9.60b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

13 Aug 2025 17:08

RNS Number : 2390V
Smith & Nephew Plc
13 August 2025
Β 

SMITH & NEPHEW PLC

Β 

13 August 2025

Β 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Β 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

Β 

On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

Β 

All figures in these columns are stated to 6 decimal places where applicable.

Β 

Β 

PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

Β 

The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

Β 

The following relates to individuals included in the below notification:

Β 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Β 

Smith & Nephew plc ordinary shares of USD 0.20 each

Β 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 12 August 2025 of Conditional Share awards granted on 11 August 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability

Date of Transaction

2025 - 08 - 12

Place of Transaction

London Stock Exchange (XLON)

Β 

Β 

Name

(Position)

Β 

Status

Price (Β£)

Volume

Aggregated information

Rohit Kashyap

(President, Advanced Wound Management and Global

PDMR

13.571365

23,201 (of which 5,670 were sold and 17,531 were retained.)

N/A Single Transaction

Β 

Β 

Β 

Helen Barraclough

Company Secretary

Smith & Nephew plc

Β 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFLFIRTEIVLIE
Date   Source Headline
7th Nov 20259:38 amRNSDirector/PDMR Shareholding
7th Nov 20259:35 amRNSDirector/PDMR Shareholding
6th Nov 20257:01 amRNSDirectorate change
6th Nov 20257:00 amRNSSmith+Nephew Third Quarter 2025 Trading Report
3rd Nov 20254:27 pmRNSTotal Voting Rights
23rd Oct 20254:14 pmRNSHolding(s) in Company
22nd Oct 20253:57 pmRNSSterling Amount of Dividend
22nd Oct 20253:24 pmRNSDividend Declaration
16th Oct 202510:10 amRNSBlock listing Interim Review
16th Oct 20258:02 amRNSNotice of Results
14th Oct 20253:45 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSCapital Markets Days
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20252:10 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSChief Financial Officer Relocation
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20254:33 pmRNSDirector/PDMR Shareholding
9th Sep 20252:06 pmRNSDirector/PDMR Shareholding
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202510:58 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 202510:57 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSDirectorate Change
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20254:25 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.